Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.

Fröhlich, Georg Marcus; De Kraker, Marlieke E A; Abbas, Mohamed; Keiser, Olivia; Thiabaud, Amaury; Roelens, Maroussia; Cusini, Alexia; Flury, Domenica; Schreiber, Peter W; Buettcher, Michael; Corti, Natascia; Vuichard-Gysin, Danielle; Troillet, Nicolas; Sauser, Julien; Gaudenz, Roman; Damonti, Lauro; Balmelli, Carlo; Iten, Anne; Widmer, Andreas; Harbarth, Stephan; ... (2022). Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Eurosurveillance, 27(1) European Centre for Disease Prevention and Control 10.2807/1560-7917.ES.2022.27.1.2001848

[img]
Preview
Text
eurosurv-27-1-5.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (241kB) | Preview

BackgroundSince the onset of the COVID-19 pandemic, the disease has frequently been compared with seasonal influenza, but this comparison is based on little empirical data.AimThis study compares in-hospital outcomes for patients with community-acquired COVID-19 and patients with community-acquired influenza in Switzerland.MethodsThis retrospective multi-centre cohort study includes patients > 18 years admitted for COVID-19 or influenza A/B infection determined by RT-PCR. Primary and secondary outcomes were in-hospital mortality and intensive care unit (ICU) admission for patients with COVID-19 or influenza. We used Cox regression (cause-specific and Fine-Gray subdistribution hazard models) to account for time-dependency and competing events with inverse probability weighting to adjust for confounders.ResultsIn 2020, 2,843 patients with COVID-19 from 14 centres were included. Between 2018 and 2020, 1,381 patients with influenza from seven centres were included; 1,722 (61%) of the patients with COVID-19 and 666 (48%) of the patients with influenza were male (p < 0.001). The patients with COVID-19 were younger (median 67 years; interquartile range (IQR): 54-78) than the patients with influenza (median 74 years; IQR: 61-84) (p < 0.001). A larger percentage of patients with COVID-19 (12.8%) than patients with influenza (4.4%) died in hospital (p < 0.001). The final adjusted subdistribution hazard ratio for mortality was 3.01 (95% CI: 2.22-4.09; p < 0.001) for COVID-19 compared with influenza and 2.44 (95% CI: 2.00-3.00, p < 0.001) for ICU admission.ConclusionCommunity-acquired COVID-19 was associated with worse outcomes compared with community-acquired influenza, as the hazards of ICU admission and in-hospital death were about two-fold to three-fold higher.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Damonti, Lauro (B), Sommerstein, Rami

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1560-7917

Publisher:

European Centre for Disease Prevention and Control

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

19 Jan 2022 11:31

Last Modified:

29 Mar 2023 23:38

Publisher DOI:

10.2807/1560-7917.ES.2022.27.1.2001848

PubMed ID:

34991775

Uncontrolled Keywords:

COVID-19 ICU Influenza Switzerland air-borne infections clinic epidemiology influenza influenza virus mortality severe acute respiratory syndrome – SARS surveillance viral infections

BORIS DOI:

10.48350/164328

URI:

https://boris.unibe.ch/id/eprint/164328

Actions (login required)

Edit item Edit item
Provide Feedback